Summary
This report studies the Irritable Bowel Syndrome Treatment market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Irritable Bowel Syndrome Treatment market by product type and application/end industries.
The global Irritable Bowel Syndrome Treatment market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Irritable Bowel Syndrome Treatment.
United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.
Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Irritable Bowel Syndrome Treatment in these regions, from 2013 to 2025 (forecast), covering
United States
North America
Europe
Asia-Pacific
South America
Middle East and Africa
The major players in global and United States market, including
Abbott Laboratories
Synergy Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc.
Valeant Pharmaceuticals International, Inc.
Ardelyx, Inc.
Astellas Pharma Inc.
Novartis AG
GlaxoSmithKline plc.
Ironwood Pharmaceuticals, Inc.
On the basis of product, the market is primarily split into
Lubiprostone
Linaclotide
Eluxadoline
Rifaximin
Ramosetron Hydrochloride
Others
On the basis on the end users/application, this report covers
Hospital
Clinic
Home Care
Table of Contents
2018-2025 Irritable Bowel Syndrome Treatment Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
1 Methodology and Data Source
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
1.2.1 Secondary Sources
1.2.2 Primary Sources
1.3 Disclaimer
2 Irritable Bowel Syndrome Treatment Market Overview
2.1 Irritable Bowel Syndrome Treatment Product Overview
2.2 Irritable Bowel Syndrome Treatment Market Segment by Type
2.2.1 Lubiprostone
2.2.2 Linaclotide
2.2.3 Eluxadoline
2.2.4 Rifaximin
2.2.5 Ramosetron Hydrochloride
2.2.6 Others
2.3 Global Irritable Bowel Syndrome Treatment Product Segment by Type
2.3.1 Global Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
2.3.2 Global Irritable Bowel Syndrome Treatment Sales (K Pcs) and Market Share (%) by Type (2013-2018)
2.3.3 Global Irritable Bowel Syndrome Treatment Revenue (Million USD) and Market Share (%) by Type (2013-2018)
2.3.4 Global Irritable Bowel Syndrome Treatment Price (USD/Pcs) by Type (2013-2018)
2.4 United States Irritable Bowel Syndrome Treatment Product Segment by Type
2.4.1 United States Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
2.4.2 United States Irritable Bowel Syndrome Treatment Sales (K Pcs) and Market Share by Type (2013-2018)
2.4.3 United States Irritable Bowel Syndrome Treatment Revenue (Million USD) and Market Share by Type (2013-2018)
2.4.4 United States Irritable Bowel Syndrome Treatment Price (USD/Pcs) by Type (2013-2018)
3 Irritable Bowel Syndrome Treatment Application/End Users
3.1 Irritable Bowel Syndrome Treatment Segment by Application/End Users
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Home Care
3.2 Global Irritable Bowel Syndrome Treatment Product Segment by Application
3.2.1 Global Irritable Bowel Syndrome Treatment Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
3.2.2 Global Irritable Bowel Syndrome Treatment Sales (K Pcs) and Market Share (%) by Application (2013-2018)
3.3 United States Irritable Bowel Syndrome Treatment Product Segment by Application
3.3.1 United States Irritable Bowel Syndrome Treatment Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
3.3.2 United States Irritable Bowel Syndrome Treatment Sales (K Pcs) and Market Share (%) by Application (2013-2018)
4 Irritable Bowel Syndrome Treatment Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Irritable Bowel Syndrome Treatment Market Size and CAGR by Regions (2013, 2017 and 2025)
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.1.7 United States
4.2 Global Irritable Bowel Syndrome Treatment Sales and Revenue by Regions
4.2.1 Global Irritable Bowel Syndrome Treatment Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
4.2.2 Global Irritable Bowel Syndrome Treatment Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
4.2.3 Global Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.4 North America Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.5 Europe Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.6 Asia-Pacific Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.7 South America Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
4.2.8 Middle East and Africa Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.9 United States Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
5 Global Irritable Bowel Syndrome Treatment Market Competition by Players/Manufacturers
5.1 Global Irritable Bowel Syndrome Treatment Sales (K Pcs) and Market Share by Players (2013-2018)
5.2 Global Irritable Bowel Syndrome Treatment Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global Irritable Bowel Syndrome Treatment Average Price (USD/Pcs) by Players (2013-2018)
5.4 Global Top Players Irritable Bowel Syndrome Treatment Manufacturing Base Distribution, Sales Area, Product Types
5.5 Irritable Bowel Syndrome Treatment Market Competitive Situation and Trends
5.5.1 Irritable Bowel Syndrome Treatment Market Concentration Rate
5.5.2 Global Irritable Bowel Syndrome Treatment Market Share (%) of Top 3 and Top 5 Players
5.5.3 Mergers & Acquisitions, Expansion
6 United States Irritable Bowel Syndrome Treatment Market Competition by Players/Manufacturers
6.1 United States Irritable Bowel Syndrome Treatment Sales (K Pcs) and Market Share by Players (2013-2018)
6.2 United States Irritable Bowel Syndrome Treatment Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States Irritable Bowel Syndrome Treatment Average Price (USD/Pcs) by Players (2013-2018)
6.4 United States Irritable Bowel Syndrome Treatment Market Share (%) of Top 3 and Top 5 Players
7 Irritable Bowel Syndrome Treatment Players/Manufacturers Profiles and Sales Data
7.1 Abbott Laboratories
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Abbott Laboratories Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.1.4 Main Business/Business Overview
7.2 Synergy Pharmaceuticals, Inc.
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Synergy Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.2.4 Main Business/Business Overview
7.3 Sucampo Pharmaceuticals, Inc.
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Sucampo Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.3.4 Main Business/Business Overview
7.4 Valeant Pharmaceuticals International, Inc.
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Valeant Pharmaceuticals International, Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.4.4 Main Business/Business Overview
7.5 Ardelyx, Inc.
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Ardelyx, Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.5.4 Main Business/Business Overview
7.6 Astellas Pharma Inc.
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Astellas Pharma Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.6.4 Main Business/Business Overview
7.7 Novartis AG
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Novartis AG Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.7.4 Main Business/Business Overview
7.8 GlaxoSmithKline plc.
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 GlaxoSmithKline plc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.8.4 Main Business/Business Overview
7.9 Ironwood Pharmaceuticals, Inc.
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Ironwood Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.9.4 Main Business/Business Overview
8 Irritable Bowel Syndrome Treatment Manufacturing Cost, Industrial Chain and Downstream Buyers
8.1 Irritable Bowel Syndrome Treatment Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Irritable Bowel Syndrome Treatment Industrial Chain Analysis
8.4 Downstream Buyers in United States
9 Marketing Strategy Analysis, Distributors and Market Effect Factors
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
9.3.1 Economic/Political Environmental Change
9.3.2 Downstream Demand Change
9.3.3 Technology Progress in Related Industry
9.3.4 Substitutes Threat
10 Global Irritable Bowel Syndrome Treatment Market Forecast
10.1 Global Irritable Bowel Syndrome Treatment Sales, Revenue Forecast (2018-2025)
10.1.1 Global Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
10.1.2 Global Irritable Bowel Syndrome Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.2 United States Irritable Bowel Syndrome Treatment Market Forecast
10.2.1 United States Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
10.2.2 United States Irritable Bowel Syndrome Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global Irritable Bowel Syndrome Treatment Forecast by Regions
10.3.1 North America Irritable Bowel Syndrome Treatment Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.2 Europe Irritable Bowel Syndrome Treatment Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.3 Asia-Pacific Irritable Bowel Syndrome Treatment Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.4 South America Irritable Bowel Syndrome Treatment Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.5 Middle East and Africa Irritable Bowel Syndrome Treatment Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.4 Irritable Bowel Syndrome Treatment Forecast by Type
10.4.1 Global Irritable Bowel Syndrome Treatment Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.4.2 United States Irritable Bowel Syndrome Treatment Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 Irritable Bowel Syndrome Treatment Forecast by Application
10.5.1 Global Irritable Bowel Syndrome Treatment Sales (K Pcs) Forecast by Application (2018-2025)
10.5.2 United States Irritable Bowel Syndrome Treatment Sales (K Pcs) Forecast by Application (2018-2025)
11 Research Findings and Conclusion
List of Tables and Figures
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Irritable Bowel Syndrome Treatment Product Picture
Figure Global Irritable Bowel Syndrome Treatment Revenue (Million USD) Status and Outlook (2013-2025)
Figure United States Irritable Bowel Syndrome Treatment Revenue (Million USD) Status and Outlook (2013-2025)
Figure Product Picture of Lubiprostone
Table Major Players of Lubiprostone
Figure Global Lubiprostone Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Linaclotide
Table Major Players of Linaclotide
Figure Global Linaclotide Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Eluxadoline
Table Major Players of Eluxadoline
Figure Global Eluxadoline Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Rifaximin
Table Major Players of Rifaximin
Figure Global Rifaximin Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Ramosetron Hydrochloride
Table Major Players of Ramosetron Hydrochloride
Figure Global Ramosetron Hydrochloride Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Pcs) and Growth Rate (%)(2013-2018)
Table Global Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table Global Irritable Bowel Syndrome Treatment Sales (K Pcs) by Type (2013-2018)
Table Global Irritable Bowel Syndrome Treatment Sales Share (%) by Type (2013-2018)
Figure Global Irritable Bowel Syndrome Treatment Sales Market Share (%) by Type (2013-2018)
Figure Global Irritable Bowel Syndrome Treatment Sales Market Share (%) by Type in 2017
Table Global Irritable Bowel Syndrome Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Irritable Bowel Syndrome Treatment Revenue Share (%) by Type (2013-2018)
Figure Global Irritable Bowel Syndrome Treatment Revenue Share (%) by Type (2013-2018)
Figure 2017 Global Irritable Bowel Syndrome Treatment Revenue Market Share (%) by Type
Table Global Irritable Bowel Syndrome Treatment Price (USD/Pcs) by Type (2013-2018)
Table United States Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table United States Irritable Bowel Syndrome Treatment Sales (K Pcs) by Type (2013-2018)
Table United States Irritable Bowel Syndrome Treatment Sales Share (%) by Type (2013-2018)
Figure United States Irritable Bowel Syndrome Treatment Sales Market Share (%) by Type (2013-2018)
Figure United States Irritable Bowel Syndrome Treatment Sales Market Share (%) by Type in 2017
Table United States Irritable Bowel Syndrome Treatment Revenue (Million USD) by Type (2013-2018)
Table United States Irritable Bowel Syndrome Treatment Revenue Share (%) by Type (2013-2018)
Figure United States Irritable Bowel Syndrome Treatment Revenue Share (%)by Type (2013-2018)
Figure 2017 United States Irritable Bowel Syndrome Treatment Revenue Market Share (%) by Type
Table United States Irritable Bowel Syndrome Treatment Price (USD/Pcs) by Type (2013-2018)
Figure Hospital Examples
Figure Clinic Examples
Figure Home Care Examples
Table Global Irritable Bowel Syndrome Treatment Sales (K Pcs) Comparison by Application (2013-2025)
Table Global Irritable Bowel Syndrome Treatment Sales (K Pcs) by Application (2013-2018)
Table Global Irritable Bowel Syndrome Treatment Sales Share (%) by Application (2013-2018)
Figure Global Irritable Bowel Syndrome Treatment Sales Market Share (%) by Application (2013-2018)
Figure Global Irritable Bowel Syndrome Treatment Sales Market Share (%) by Application in 2017
Table United States Irritable Bowel Syndrome Treatment Sales (K Pcs) Comparison by Application (2013-2025)
Table United States Irritable Bowel Syndrome Treatment Sales (K Pcs) by Application (2013-2018)
Table United States Irritable Bowel Syndrome Treatment Sales Share (%) by Application (2013-2018)
Figure United States Irritable Bowel Syndrome Treatment Sales Market Share (%) by Application (2013-2018)
Figure United States Irritable Bowel Syndrome Treatment Sales Market Share (%) by Application in 2017
Table Global Irritable Bowel Syndrome Treatment Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
Figure North America Irritable Bowel Syndrome Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Asia-Pacific Irritable Bowel Syndrome Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Europe Irritable Bowel Syndrome Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure South America Irritable Bowel Syndrome Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Middle East and Africa Irritable Bowel Syndrome Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure United States Irritable Bowel Syndrome Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Global Irritable Bowel Syndrome Treatment Sales (K Pcs) by Regions (2013-2018)
Table Global Irritable Bowel Syndrome Treatment Sales Market Share (%) by Regions (2013-2018)
Figure Global Irritable Bowel Syndrome Treatment Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Irritable Bowel Syndrome Treatment Sales Market Share (%) by Regions
Figure 2017 United States Irritable Bowel Syndrome Treatment Sales Market Share (%) in Global Market
Table Global Irritable Bowel Syndrome Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Irritable Bowel Syndrome Treatment Revenue Market Share (%) by Regions (2013-2018)
Figure Global Irritable Bowel Syndrome Treatment Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global Irritable Bowel Syndrome Treatment Revenue Market Share (%) by Regions
Figure 2017 United States Irritable Bowel Syndrome Treatment Revenue Market Share (%) in Global Market
Table Global Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table North America Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Europe Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Asia-Pacific Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table South America Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Middle East and Africa Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table United States Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Global Irritable Bowel Syndrome Treatment Sales (K Pcs) of Key Players (2013-2018)
Table Global Irritable Bowel Syndrome Treatment Sales Share (%) by Players (2013-2018)
Figure 2017 Global Irritable Bowel Syndrome Treatment Sales Share (%) by Players
Figure 2018 Global Irritable Bowel Syndrome Treatment Sales Share (%) by Players
Table Global Irritable Bowel Syndrome Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Irritable Bowel Syndrome Treatment Revenue Share (%) by Players (2013-2018)
Table 2017 Global Irritable Bowel Syndrome Treatment Revenue Share (%) by Players
Table 2018 Global Irritable Bowel Syndrome Treatment Revenue Share (%) by Players
Table Global Market Irritable Bowel Syndrome Treatment Average Price (USD/Pcs) by Players (2013-2018)
Table Global Irritable Bowel Syndrome Treatment Top Players Manufacturing Base Distribution and Sales Area
Table Global Irritable Bowel Syndrome Treatment Top Players Product Category
Figure Global Irritable Bowel Syndrome Treatment Market Share (%) of Top 3 Players
Figure Global Irritable Bowel Syndrome Treatment Market Share (%) of Top 5 Players
Table United States Irritable Bowel Syndrome Treatment Sales (K Pcs) by Players (2013-2018)
Table United States Irritable Bowel Syndrome Treatment Sales Market Share (%) by Players (2013-2018)
Figure 2017 United States Irritable Bowel Syndrome Treatment Sales Share (%) by Players
Figure 2018 United States Irritable Bowel Syndrome Treatment Sales Share (%) by Players
Table United States Irritable Bowel Syndrome Treatment Revenue (Million USD) by Players (2013-2018)
Table United States Irritable Bowel Syndrome Treatment Revenue Market Share (%) by Players (2013-2018)
Table 2017 United States Irritable Bowel Syndrome Treatment Revenue Share (%) by Players
Table 2018 United States Irritable Bowel Syndrome Treatment Revenue Share (%) by Players
Table United States Market Irritable Bowel Syndrome Treatment Average Price (USD/Pcs) by Players (2013-2018)
Figure United States Irritable Bowel Syndrome Treatment Market Share (%) of Top 3 Players
Figure United States Irritable Bowel Syndrome Treatment Market Share (%) of Top 5 Players
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Abbott Laboratories Irritable Bowel Syndrome Treatment Sales Growth Rate (2013-2018)
Figure Abbott Laboratories Irritable Bowel Syndrome Treatment Sales Global Market Share (%)(2013-2018)
Figure Abbott Laboratories Irritable Bowel Syndrome Treatment Revenue Global Market Share (%)(2013-2018)
Table Synergy Pharmaceuticals, Inc. Basic Information List
Table Synergy Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Synergy Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales Growth Rate (2013-2018)
Figure Synergy Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales Global Market Share (%)(2013-2018)
Figure Synergy Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Revenue Global Market Share (%)(2013-2018)
Table Sucampo Pharmaceuticals, Inc. Basic Information List
Table Sucampo Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Sucampo Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales Growth Rate (2013-2018)
Figure Sucampo Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales Global Market Share (%)(2013-2018)
Figure Sucampo Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Revenue Global Market Share (%)(2013-2018)
Table Valeant Pharmaceuticals International, Inc. Basic Information List
Table Valeant Pharmaceuticals International, Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Valeant Pharmaceuticals International, Inc. Irritable Bowel Syndrome Treatment Sales Growth Rate (2013-2018)
Figure Valeant Pharmaceuticals International, Inc. Irritable Bowel Syndrome Treatment Sales Global Market Share (%)(2013-2018)
Figure Valeant Pharmaceuticals International, Inc. Irritable Bowel Syndrome Treatment Revenue Global Market Share (%)(2013-2018)
Table Ardelyx, Inc. Basic Information List
Table Ardelyx, Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Ardelyx, Inc. Irritable Bowel Syndrome Treatment Sales Growth Rate (2013-2018)
Figure Ardelyx, Inc. Irritable Bowel Syndrome Treatment Sales Global Market Share (%)(2013-2018)
Figure Ardelyx, Inc. Irritable Bowel Syndrome Treatment Revenue Global Market Share (%)(2013-2018)
Table Astellas Pharma Inc. Basic Information List
Table Astellas Pharma Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Astellas Pharma Inc. Irritable Bowel Syndrome Treatment Sales Growth Rate (2013-2018)
Figure Astellas Pharma Inc. Irritable Bowel Syndrome Treatment Sales Global Market Share (%)(2013-2018)
Figure Astellas Pharma Inc. Irritable Bowel Syndrome Treatment Revenue Global Market Share (%)(2013-2018)
Table Novartis AG Basic Information List
Table Novartis AG Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Novartis AG Irritable Bowel Syndrome Treatment Sales Growth Rate (2013-2018)
Figure Novartis AG Irritable Bowel Syndrome Treatment Sales Global Market Share (%)(2013-2018)
Figure Novartis AG Irritable Bowel Syndrome Treatment Revenue Global Market Share (%)(2013-2018)
Table GlaxoSmithKline plc. Basic Information List
Table GlaxoSmithKline plc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure GlaxoSmithKline plc. Irritable Bowel Syndrome Treatment Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline plc. Irritable Bowel Syndrome Treatment Sales Global Market Share (%)(2013-2018)
Figure GlaxoSmithKline plc. Irritable Bowel Syndrome Treatment Revenue Global Market Share (%)(2013-2018)
Table Ironwood Pharmaceuticals, Inc. Basic Information List
Table Ironwood Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Ironwood Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales Growth Rate (2013-2018)
Figure Ironwood Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales Global Market Share (%)(2013-2018)
Figure Ironwood Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Revenue Global Market Share (%)(2013-2018)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Irritable Bowel Syndrome Treatment
Figure Irritable Bowel Syndrome Treatment Industrial Chain Analysis
Table Major Buyers of Irritable Bowel Syndrome Treatment
Table Distributors/Traders List
Figure Global Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Global Irritable Bowel Syndrome Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Figure United States Irritable Bowel Syndrome TreatmentIrritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure United States Irritable Bowel Syndrome Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Table Global Irritable Bowel Syndrome Treatment Sales (K Pcs) Forecast by Regions (2018-2025)
Figure Global Irritable Bowel Syndrome Treatment Sales Market Share (%) Forecast by Regions (2018-2025)
Figure North America Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure North America Irritable Bowel Syndrome Treatment Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Europe Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Europe Irritable Bowel Syndrome Treatment Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Irritable Bowel Syndrome Treatment Revenue and Growth Rate (%) Forecast (2018-2025)
Figure South America Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure South America Irritable Bowel Syndrome Treatment Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Irritable Bowel Syndrome Treatment Revenue and Growth Rate (%) Forecast (2018-2025)
Table Global Irritable Bowel Syndrome Treatment Sales (Million USD) Forecast by Type (2018-2025)
Figure Global Irritable Bowel Syndrome Treatment Sales Market Share (%) Forecast by Type (2018-2025)
Table Global Irritable Bowel Syndrome Treatment Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Irritable Bowel Syndrome Treatment Revenue Market Share (%) Forecast by Type (2018-2025)
Table United States Irritable Bowel Syndrome Treatment Sales (Million USD) Forecast by Type (2018-2025)
Figure United States Irritable Bowel Syndrome Treatment Sales Market Share (%) Forecast by Type (2018-2025)
Table United States Irritable Bowel Syndrome Treatment Revenue (Million USD) Forecast by Type (2018-2025)
Figure United States Irritable Bowel Syndrome Treatment Revenue Market Share (%) Forecast by Type (2018-2025)
Table Global Irritable Bowel Syndrome Treatment Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Irritable Bowel Syndrome Treatment Sales Forecast by Application (2018-2025)
Table United States Irritable Bowel Syndrome Treatment Sales (K Pcs) Forecast by Application (2018-2025)
Figure United States Irritable Bowel Syndrome Treatment Sales Forecast by Application (2018-2025)
